Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey ( SWAY )

Author:

Osunkwo Ifeyinwa1,Andemariam Biree2,Minniti Caterina P.3ORCID,Inusa Baba P. D.4ORCID,El Rassi Fuad5,Francis‐Gibson Beverley6,Nero Alecia7,Trimnell Cassandra8,Abboud Miguel R.9,Arlet Jean‐Benoît10,Colombatti Raffaella11,Montalembert Mariane12,Jain Suman13,Jastaniah Wasil14,Nur Erfan15,Pita Marimilia16,DeBonnett Laurie17,Ramscar Nicholas18,Bailey Tom19,Rajkovic‐Hooley Olivera19,James John20

Affiliation:

1. Sickle Cell Disease Enterprise The Levine Cancer Institute, Atrium Health Charlotte North Carolina USA

2. New England Sickle Cell Institute, University of Connecticut Health Farmington Connecticut USA

3. Albert Einstein College of Medicine New York New York USA

4. Evelina Childrenʼs Hospital Guyʼs and St Thomasʼ NHS Foundation Trust London UK

5. Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System Atlanta Georgia USA

6. Sickle Cell Disease Association of America Baltimore Maryland USA

7. University of Texas Southwestern Medical Center Dallas Texas USA

8. Sickle Cell 101 San Jose California USA

9. American University of Beirut Medical Center Beirut Lebanon

10. Sickle Cell Disease Referral Centre, Internal Medicine Department, Hôpital Européen Georges‐Pompidou, AP‐HP Université de Paris Paris France

11. Azienda Ospedale‐Università di Padova Padova Italy

12. Hôpital Universitaire Necker‐Enfants Malades Paris France

13. Thalassemia and Sickle Cell Society Hyderabad India

14. Umm Al‐Qura University Mecca Saudi Arabia

15. Academic Medical Center Amsterdam The Netherlands

16. Pediatric Hematology, Hospital Samaritano Laureate University‐UAM São Paulo Brazil

17. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA

18. Novartis Pharma AG Basel Switzerland

19. Adelphi Real World Bollington UK

20. Sickle Cell Society London UK

Funder

Novartis

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3